PRIMUS-001

Trial description
An adaptive phase II study of FOLFOX-A (FOLFOX and nab-paclitaxel) versus AG (nab-paclitaxel and gemcitabine) in patients with metastatic pancreatic cancer, with integrated biomarker evaluation
Contact name
Dr Pippa Corrie
Trial start date
Thursday, May 10, 2018
Trial end date
Friday, August 30, 2019
Trial tumour type
Pancreatic
Show on Radiotherapy
No